BIENCA (SA)

Active

VAT

BE 0446.755.472

Full name

Biotechnological Enzymatic Catalyse

Address

Industriepark 13

9820 Merelbeke

Established

26-02-1992

Principal activity

Wholesale trade of pharmaceutical goods

Try for free

Crisis resilience of BIENCA

Which companies are best armed against current economic trends and the energy crisis?

2023		2022		2021		2020
Profit/Loss	€314,643	-30%	€446,937	71%	€260,645	482%	-€68,212
Equity	€745,291	-59%	€1,830,797	32%	€1,383,860	23%	€1,123,214
Gross margin	€388,768	0%	€388,804	-29%	€550,345	316%	€132,402
Employees	0,8 FTE	-	-	-	2,9 FTE	38%	2,1 FTE

Publications in the Belgian Official Journal for BIENCA

Type	Date	Pdf	Subject
	12-05-2023		Articles of Association (Translation, Coordination, Other Modifications, …) - Designation - Miscella… (NL)
	08-03-2023		Resignations - Appointments (NL)
	12-09-2022		Resignations, Appointments (FR)
	20-10-2021		Resignations - Appointments - Registered Office - Adressen Anders Dan Registered Office (NL)
	15-10-2020		Resignations - Appointments (NL)

Sources

Frequently asked questions

What is the VAT number of Biotechnological Enzymatic Catalyse?

The VAT number of Biotechnological Enzymatic Catalyse is BE0446755472.

When was Biotechnological Enzymatic Catalyse founded?

Biotechnological Enzymatic Catalyse was founded on 26-02-1992.

What is the address of Biotechnological Enzymatic Catalyse?

The current registered office of Biotechnological Enzymatic Catalyse is located at Industriepark 13, 9820 Merelbeke.

When was the last time Biotechnological Enzymatic Catalyse filed their annual financial statements?

The most recent financial statements of Biotechnological Enzymatic Catalyse were filed on 03-06-2024. You can view them here.

How many employees does Biotechnological Enzymatic Catalyse have?

There are 0,8 FTEs working at Biotechnological Enzymatic Catalyse according to the staff figures in the most recent financial statements.

What is the annual turnover of Biotechnological Enzymatic Catalyse?

At the time of its most recent financial statements, Biotechnological Enzymatic Catalyse did not publish any turnover figures. Biotechnological Enzymatic Catalyse reported a gross margin of €388,768.00.